RÉSUMÉ
The transforming growth factor beta-activated kinase 1 (TAK1)/c-Jun N-terminal kinase (JNK) axis is an essential MAPK upstream mediator and regulates immune signaling pathways. However, whether the TAK1/JNK axis harnesses the strength in regulation of signal transduction in early vertebrate adaptive immunity is unclear. In this study, by modeling on Nile tilapia (Oreochromis niloticus), we investigated the potential regulatory function of TAK1/JNK axis on lymphocyte-mediated adaptive immune response. Both OnTAK1 and OnJNK exhibited highly conserved sequences and structures relative to their counterparts in other vertebrates. Their mRNA was widely expressed in the immune-associated tissues, while phosphorylation levels in splenic lymphocytes were significantly enhanced on the 4th day post-infection by Edwardsiella piscicida. In addition, OnTAK1 and OnJNK were significantly up-regulated in transcriptional level after activation of lymphocytes in vitro by phorbol 12-myristate 13-acetate plus ionomycin (P + I) or PHA, accompanied by a predominant increase in phosphorylation level. More importantly, inhibition of OnTAK1 activity by specific inhibitor NG25 led to a significant decrease in the phosphorylation level of OnJNK. Furthermore, blocking the activity of OnJNK with specific inhibitor SP600125 resulted in a marked reduction in the expression of T-cell activation markers including IFN-γ, CD122, IL-2, and CD44 during PHA-induced T-cell activation. In summary, these findings indicated that the conserved TAK1/JNK axis in Nile tilapia was involved in adaptive immune responses by regulating the activation of lymphocytes. This study enriched the current knowledge of adaptive immunity in teleost and provided a new perspective for understanding the regulatory mechanism of fish immunity.
Sujet(s)
Immunité acquise , Cichlides , Maladies des poissons , Protéines de poisson , Activation des lymphocytes , MAP Kinase Kinase Kinases , Animaux , Cichlides/immunologie , Cichlides/génétique , Protéines de poisson/génétique , Protéines de poisson/immunologie , Maladies des poissons/immunologie , MAP Kinase Kinase Kinases/génétique , MAP Kinase Kinase Kinases/immunologie , Infections à Enterobacteriaceae/immunologie , Infections à Enterobacteriaceae/médecine vétérinaire , Edwardsiella/immunologie , Edwardsiella/physiologie , Régulation de l'expression des gènes/immunologie , Transduction du signal/immunologie , Analyse de profil d'expression de gènes/médecine vétérinaire , Phylogenèse , Alignement de séquences/médecine vétérinaire , Séquence d'acides aminésRÉSUMÉ
Antimicrobial resistance and biofilm formation by microbial pathogens pose a significant challenge to poultry production systems due to the persistent risk of dissemination and compromise of bird health and productivity. In this context, the study aimed to investigate the occurrence of different multiresistance phenotypes and the biofilm-forming ability of Enterobacteriaceae isolated from broiler chicken excreta in poultry production units in Ceará, Brazil. Samples were collected from three distinct broiler breeding facilities and subjected to isolation, identification, antibiotic susceptibility testing, phenotypic screening for ß-lactamases enzymes, and biofilm formation evaluation. Seventy-one strains were identified, being Escherichia coli (37 %) and Proteus mirabilis (32 %), followed by Klebsiella pneumoniae (11 %), Providencia stuartii (9 %), Klebsiella aerogenes (6 %), Alcaligenes faecalis (4 %), and Salmonella sp. (1 %). A significant proportion (87 %) of multiresistant strains were detected. For the phenotypic evaluation of ß-lactamases production, strains with resistance to second and third-generation cephalosporins and carbapenems were tested. About 4 of 6 and 10 of 26 were positive for inducible chromosomal AmpC ß-lactamase and extended-spectrum ß-lactamase (ESBL), respectively. Regarding biofilm formation, it was observed that all MDR strains were capable of forming biofilm. In this sense the potential of these MDR bacteria to develop biofilms becomes a significant concern, representing a real threat to both human and animal health, as biofilms offer stability, antimicrobial protection, and facilitate genetic transfer.
Sujet(s)
Antibactériens , Biofilms , Poulets , Multirésistance bactérienne aux médicaments , Enterobacteriaceae , Fermes , Fèces , Tests de sensibilité microbienne , bêta-Lactamases , Animaux , Biofilms/croissance et développement , Biofilms/effets des médicaments et des substances chimiques , Brésil , bêta-Lactamases/génétique , bêta-Lactamases/métabolisme , Fèces/microbiologie , Enterobacteriaceae/effets des médicaments et des substances chimiques , Enterobacteriaceae/isolement et purification , Enterobacteriaceae/génétique , Antibactériens/pharmacologie , Poulets/microbiologie , Protéines bactériennes/génétique , Protéines bactériennes/métabolisme , Volaille/microbiologie , Infections à Enterobacteriaceae/microbiologie , Infections à Enterobacteriaceae/médecine vétérinaireRÉSUMÉ
Edwardsiellosis is a bacterial fish disease that mostly occurs in freshwater farms and is characterized by a high mortality rate. Edwardsiella tarda strain was recovered from 17 fish out of 50 Nile tilapia, which were harboring clinical signs of systemic septicemia. The level of un-ionized ammonia (NH3) in the fish farm's water was 0.11-0.15 mg/L, which was stressful for the Nile tilapia.Sequencing of the gyrB1 gene confirmed that the isolate was E. tarda JALO4, and it was submitted to NCBI under the accession number PP449014. The isolated E. tarda harbored the virulence gene edw1 AHL-synthase (quorum sensing). In addition, the isolate was sensitive to trimethoprim and sulfamethoxazole mean while it was intermediate to florfenicol. The median lethal dose (LD50) of E. tarda JALO4 was determined to be 1.7 × 105 CFU/mL in Nile tilapia.In the indoor experiment, Nile tilapia (45.05 ± 0.4 g), which received dietary Spirulina platensis (5 and 10 g/kg fish feed), showed optimum growth and feed utilization. Meanwhile, after receiving dietary S. platensis, the fish's feed conversion ratio (FCR) was significantly enhanced compared to the control, which was 1.94, 1.99, and 2.88, respectively. The expression of immune-related genes interleukin (IL)-1ß and tumor necrosis factor (TNF)-α were upsurged in E. tarda-challenged fish with higher intensity in S. platensis groups. Dietary S. platensis at a dose of 10 g/kg fish feed could provide a relative protection level (RPL) of 22.2% Nile tilapia challenged against E. tarda. Nile tilapia experimentally infected E. tarda, drastically altering their behavior: higher operculum movement, low food apprehension, and abnormal swimming dietary S. platensis (10 g/kg fish feed) could rapidly restore normal status.It was concluded that Edwardsiellosis could alter Nile tilapia behavior with a high loss in fish population. Fish received dietary-S. platensis could rapidly restore normal behavior after E. tarda infection. It is recommended the incorporation of S. platensis at doses of 10 g/kg into the Nile tilapia diet to boost their immunity and counteract E. tarda infection.
Sujet(s)
Aliment pour animaux , Cichlides , Edwardsiella tarda , Infections à Enterobacteriaceae , Maladies des poissons , Spirulina , Animaux , Cichlides/immunologie , Maladies des poissons/prévention et contrôle , Maladies des poissons/microbiologie , Maladies des poissons/immunologie , Aliment pour animaux/analyse , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/prévention et contrôle , Aquaculture , Régime alimentaire/médecine vétérinaireRÉSUMÉ
The research examined the impact of an ethanolic extract from the leaves of Kratom (Mitragyna speciosa (Korth.) Havil.) on the growth, antioxidant capacity, immune-related gene expression, and resistance to disease caused by Edwardsiella tarda in Nile tilapia (Oreochromis niloticus). The findings revealed that the extract had the important phytochemical content in the extract included total phenolics content, total flavonoids content, vitamin C, and total antioxidant capacity and 5.42 % of the crude extract was mitragynine. The extract demonstrated antioxidant activity, as evidenced by its IC50 values against ABTS and DPPH radicals and its ferric reducing power in vitro. Moreover, the MIC-IC50 value of 0.625 mg/mL indicated that the growth of the bacteria was reduced by approximately 50 %, and the MBC was 2.50 mg/mL against E. tarda. Furthermore, the orally administered Kratom leaf extract to fingerling tilapia for 8 weeks exhibited a noticeable increase in oxidative stress, as demonstrated by the increase in MDA production in the 10 and 25 g/kg groups. It also exhibited an increase in acetylcholinesterase (AChE) activity in muscle tissue at the 50 g/kg group. However, when administered at a feeding rate of 5-10 g/kg feed, the extract showed an increase in the expression of immune-related genes (IL1, IL6, IL8, NF-kB, IFNγ, TNFα, Mx, CC-chemokine, CD4, TCRß, MHC-IIß, IgM, IgT, IgD) and enhanced resistance to E. tarda infection in fish. Conversely, administering the extract at 25-50 g/kg feed resulted in contrasting effects, suppressing and reducing the observed parameters. Nevertheless, feeding the extract at all concentrations for 8 weeks did not produce any changes in the histology or systemic functioning of the liver and intestines, as indicated by blood biochemistry. These findings suggest that the ethanolic leaf extract from Kratom has the potential to be used as a substitute for antibiotics in the management of bacterial infections in Nile tilapia culture, with a recommended dosage of 5-10 g/kg feed/day for a maximum of 8 weeks.
Sujet(s)
Antibactériens , Antioxydants , Cichlides , Edwardsiella tarda , Infections à Enterobacteriaceae , Maladies des poissons , Mitragyna , Extraits de plantes , Feuilles de plante , Animaux , Maladies des poissons/immunologie , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Extraits de plantes/administration et posologie , Cichlides/immunologie , Cichlides/croissance et développement , Edwardsiella tarda/effets des médicaments et des substances chimiques , Edwardsiella tarda/physiologie , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/immunologie , Antioxydants/pharmacologie , Feuilles de plante/composition chimique , Antibactériens/pharmacologie , Mitragyna/composition chimique , Résistance à la maladie/effets des médicaments et des substances chimiques , Régime alimentaire/médecine vétérinaire , Aliment pour animaux/analyse , Compléments alimentaires/analyseRÉSUMÉ
Intracellular bacteria such as those belonging to the genus Edwardsiella can survive and proliferate within macrophages. However, the detailed mechanisms underlying the host macrophage immune response and pathogen evasion strategies remain unknown. To advance the field of host macrophage research, we successfully established transgenic (Tg) Japanese medaka Oryzias latipes that possesses fluorescently visualized macrophages. As a macrophage marker, the macrophage-expressed gene 1.1 (mpeg1.1) was selected because of its predominant expression across various tissues in medaka. To validate the macrophage characteristics of the fluorescently labeled cells, May-Grünwald Giemsa staining and peroxidase staining were conducted. The labeled cells exhibited morphological features consistent with those of monocyte/macrophage-like cells and tested negative for peroxidase activity. Through co-localization studies, the fluorescently labeled cells co-localized with E. piscicida in the intestines and kidneys of infected medaka larvae, confirming the ingestion of bacteria through phagocytosis. In addition, the labeled cells expressed macrophage markers but lacked a neutrophil marker. These results suggested that the fluorescently labeled cells of Tg[mpeg1.1:mCherry/mAG] medaka were monocytes/macrophages, which will be useful for future studies aimed at understanding the mechanisms of macrophage-mediated bacterial infections.
Sujet(s)
Animal génétiquement modifié , Edwardsiella , Infections à Enterobacteriaceae , Maladies des poissons , Macrophages , Oryzias , Phagocytose , Animaux , Oryzias/génétique , Macrophages/microbiologie , Macrophages/métabolisme , Macrophages/immunologie , Edwardsiella/génétique , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/immunologie , Infections à Enterobacteriaceae/microbiologie , Maladies des poissons/microbiologie , Maladies des poissons/immunologie , Larve/microbiologie , Larve/génétique , Larve/immunologieRÉSUMÉ
One of the most significant research areas in veterinary medicine is the search for carbapenem substitutes for the treatment of extended-spectrum ß-lactamase (ESBL)-producing Enterobacterales (ESBL-E). This study applied a pharmacokinetic/pharmacodynamic (PK/PD) strategy in validating optimal latamoxef (LMX) therapeutic regimens against canine ESBL-E infections. Five dogs were administered a bolus dose of 40 mg/kg LMX intravenously to measure serum drug concentrations and determine PK indices using the noncompartmental model. The highest minimum inhibitory concentration (MIC) with a probability of target attainment ≥90% was used to compute the PK/PD cutoff values for bacteriostatic (time for which the unbound drug concentration was above the MIC [fTAM] ≥ 40%) and bactericidal (fTAM ≥ 70%) effects when administered at 20, 30, 50, and 60 mg/kg, in addition to 40 mg/kg. The cumulative fraction of response (CFR) was determined using the MIC distribution of wild-type ESBL-E in companion animals. The PK/PD cutoff values can be increased by reducing the dosing interval rather than increasing the dose per time. Based on the calculated CFRs for ESBL-producing Escherichia coli and Klebsiella pneumoniae, all LMX regimens in this study and those administered at 30-60 mg/kg every 8 and 6 hr were found to be optimal (CFR ≥ 90%) for exerting bacteriostatic and bactericidal effects, respectively. However, the regimens of 50 and 60 mg/kg every 6 hr may merely exert bacteriostatic effects on ESBL-producing Enterobacter cloacae. Further clinical trials are required to confirm the clinical efficacy of LMX.
Sujet(s)
Antibactériens , Maladies des chiens , Infections à Enterobacteriaceae , Tests de sensibilité microbienne , Méthode de Monte Carlo , Latamoxef , bêta-Lactamases , Animaux , Chiens , Antibactériens/pharmacocinétique , Antibactériens/pharmacologie , Antibactériens/administration et posologie , Maladies des chiens/traitement médicamenteux , Maladies des chiens/microbiologie , bêta-Lactamases/métabolisme , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/traitement médicamenteux , Latamoxef/pharmacocinétique , Latamoxef/pharmacologie , Latamoxef/administration et posologie , Enterobacteriaceae/effets des médicaments et des substances chimiques , Mâle , Femelle , Relation dose-effet des médicamentsRÉSUMÉ
Edwardsiella anguillarum, a highly virulent species within the Edwardsiella genus, causes significant mortality in milkfish farms in Taiwan. This study aimed to investigate the comparison of milkfish susceptibility, a newly identified host species in Taiwanese aquaculture, with other species Nile tilapia (Oreochromis niloticus) and Asian seabass (Lates calcarifer), to E. anguillarum, elucidating its pathogenicity across both seawater and freshwater aquaculture environments. The results showed milkfish exhibited the highest mortality rate of 85% within 48 h of infection, whereas Nile tilapia exhibited a mortality rate of 70% between the second- and tenth-day post challenge, and seabass exhibited a mortality rate of 25% between the second- and sixth-day post challenge. Gross lesions observed in milkfish included splenomegaly and haemorrhage, whereas Nile tilapia exhibited signs of ascites, exophthalmia and brain haemorrhage. Seabass displayed spleen granulomas and haemorrhage at the injection site. Histopathological analysis revealed common features across all three species, including multifocal necrosis, bacterial presence in the necrotic areas, serositis and oedema. Asian seabass also exhibited chronic lesions in the form of splenic granulomas. This study highlights the high susceptibility of milkfish and Nile tilapia to E. anguillarum, emphasizing the urgent need for further investigation into targeted vaccine development for these fish species. These results not only deepen our understanding of the differing levels of pathogenicity among the three species but also offer valuable insights for improving disease prevention and management strategies in aquaculture, including those applied within polyculture systems and for the maintenance of aquaculture water environments.
Sujet(s)
Cichlides , Edwardsiella , Infections à Enterobacteriaceae , Maladies des poissons , Animaux , Maladies des poissons/microbiologie , Maladies des poissons/anatomopathologie , Maladies des poissons/prévention et contrôle , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/anatomopathologie , Infections à Enterobacteriaceae/microbiologie , Infections à Enterobacteriaceae/prévention et contrôle , Edwardsiella/pathogénicité , Virulence , Aquaculture , Taïwan , PoissonsRÉSUMÉ
The yellow catfish (Pelteobagrus fulvidraco) is one of the most economically important freshwater species in Asia. However, pathogenic bacterial infections often cause high rates of mortality and economic losses in practical aquaculture. Previous studies in mammals have shown that Toll-like receptor 2 (TLR2) and Toll-like receptor 5 (TLR5) are involved in the recognition of cell wall components such as lipopolysaccharides and flagella of various bacteria, thereby acting as key regulators in the innate immunity response. However, TLR2 and TLR5 in yellow catfish have not been characterized. In the present study, TLR2 and TLR5 were examined through comparative genomic approaches. The gene structure, collinearity, protein spatial structure, and phylogenetic relationships were compared with those in multiple representative vertebrates. Meanwhile, quantitative real-time PCR was conducted to explore transcriptional changes in TLR2 and TLR5 in immune tissues after infection with exogenous A. hydrophila and E. tarda. The results demonstrated the presence of TLR2 and TLR5 in yellow catfish. However, a systematic analysis showed that TLR2 was not associated with the arrangement of diverse neighboring genes. The expression of hybrid yellow catfish TLR2 transcripts in multiple tissues (including liver, spleen, kidney, and intestine) was significantly up-regulated after infection with A. hydrophila and E. tarda, suggesting that hybrid yellow catfish TLR2 and TLR5 may participate in the immune process. Taken together, the results indicate that TLR2 and TLR5 are conserved in terms of evolution and possess significant antibacterial activity as well as regulatory properties in immune-related tissues and thus play key roles in host defense against pathogen invasion.
Sujet(s)
Aeromonas hydrophila , Poissons-chats , Edwardsiella tarda , Infections à Enterobacteriaceae , Maladies des poissons , Protéines de poisson , Infections bactériennes à Gram négatif , Immunité innée , Phylogenèse , Récepteur de type Toll-2 , Récepteur de type Toll-5 , Animaux , Poissons-chats/immunologie , Poissons-chats/génétique , Maladies des poissons/immunologie , Protéines de poisson/génétique , Protéines de poisson/immunologie , Récepteur de type Toll-2/génétique , Récepteur de type Toll-2/immunologie , Récepteur de type Toll-2/métabolisme , Immunité innée/génétique , Aeromonas hydrophila/physiologie , Infections à Enterobacteriaceae/immunologie , Infections à Enterobacteriaceae/médecine vétérinaire , Récepteur de type Toll-5/génétique , Récepteur de type Toll-5/immunologie , Infections bactériennes à Gram négatif/immunologie , Infections bactériennes à Gram négatif/médecine vétérinaire , Edwardsiella tarda/physiologie , Analyse de profil d'expression de gènes/médecine vétérinaire , Régulation de l'expression des gènes/immunologie , TranscriptomeRÉSUMÉ
The interleukin-12 (IL-12) family is a class of heterodimeric cytokines that play crucial roles in pro-inflammatory and pro-stimulatory responses. Although some IL-12 and IL-23 paralogues have been found in fish, their functional activity in fish remains poorly understood. In this study, Pf_IL-12p35a/b, Pf_IL-23p19 and Pf_IL-12p40a/b/c genes were cloned from yellow catfish (Pelteobagrus fulvidraco), four α-helices were found in Pf_IL-12p35a/b and Pf_IL-23p19. The transcripts of these six genes were relatively high in mucus and immune tissues of healthy individuals, and in gill leukocytes. Following Edwardsiella ictaluri infection, Pf_IL-12p35a/b and Pf_IL-23p19 mRNAs were induced in brain and kidney (or head kidney), Pf_IL-12p40a mRNA was induced in gill, and Pf_IL-12p40b/c mRNAs were induced in brain and liver (or skin). The mRNA expression of these genes in PBLs was induced by phytohaemagglutinin (PHA) and polyinosinic-polycytidylic acid (poly I:C), while lipopolysaccharides (LPS) induced the mRNA expression of Pf_IL-12p35a and Pf_IL-12p40b/c in PBLs. After stimulation with recombinant (r) Pf_IL-12 and rPf_IL-23 subunit proteins, either alone or in combination, mRNA expression patterns of genes related to T helper cell development exhibited distinct differences. The results suggest that Pf_IL-12 and Pf_IL-23 subunits may play important roles in regulating immune responses to pathogens and T helper cell development.
Sujet(s)
Poissons-chats , Infections à Enterobacteriaceae , Maladies des poissons , Protéines de poisson , Analyse de profil d'expression de gènes , Régulation de l'expression des gènes , Immunité innée , Sous-unité p40 de l'interleukine-12 , Animaux , Poissons-chats/génétique , Poissons-chats/immunologie , Protéines de poisson/génétique , Protéines de poisson/immunologie , Protéines de poisson/composition chimique , Infections à Enterobacteriaceae/immunologie , Infections à Enterobacteriaceae/médecine vétérinaire , Maladies des poissons/immunologie , Régulation de l'expression des gènes/immunologie , Sous-unité p40 de l'interleukine-12/génétique , Sous-unité p40 de l'interleukine-12/immunologie , Analyse de profil d'expression de gènes/médecine vétérinaire , Immunité innée/génétique , Edwardsiella ictaluri/physiologie , Sous-unité p35 de l'interleukine-12/génétique , Sous-unité p35 de l'interleukine-12/immunologie , Phylogenèse , Séquence d'acides aminés , Alignement de séquences/médecine vétérinaire , Sous-unité p19 de l'interleukine-23/génétique , Sous-unité p19 de l'interleukine-23/immunologie , Poly I-C/pharmacologieRÉSUMÉ
The Oscar fish (Astronotus ocellatus) is among the most commonly domesticated and exported ornamental fish species from Kerala. The ornamental fish industry faces a significant challenge with the emergence of diseases caused by multi-drug-resistant bacteria. In the present study, six isolates were resolved from the diseased Oscar fish showing haemorrhages, necrosis, and loss of pigmentation. After phenotypic and genotypic characterization, the bacteria were identified as Edwardsiella tarda, Klebsiella pneumoniae, Enterococcus faecalis, Escherichia coli, Brevibacillus borstelensis, and Staphylococcus hominis. Experimental challenge studies in healthy Oscar fish showed that E. tarda caused 100% mortality within 240 h with 6.99 × 106 CFU/fish as LD50 and histopathology revealed the typical signs of infection. The pathogen was re-recovered from the moribund fish thereby confirming Koch's postulates. E. tarda was confirmed through the positive amplification of tarda-specific gene and virulence genes viz., etfD and escB were also detected using PCR. Antibiotic susceptibility tests using disc diffusion displayed that the pathogen is multi-drug-resistant towards antibiotics belonging to aminoglycosides, tetracyclines, and quinolones categories with a MAR index of 0.32, which implicated the antibiotic pressure in the farm. Plasmid curing studies showed a paradigm shift in the resistance pattern with MAR index of 0.04, highlighting the resistance genes are plasmid-borne except for the chromosome-borne tetracycline resistance gene (tetA). This study is the first of its kind in detecting mass mortality caused by E. tarda in Oscar fish. Vigilant surveillance and strategic actions are crucial for the precise detection of pathogens and AMR in aquaculture.
Sujet(s)
Antibactériens , Multirésistance bactérienne aux médicaments , Edwardsiella tarda , Infections à Enterobacteriaceae , Maladies des poissons , Tests de sensibilité microbienne , Animaux , Maladies des poissons/microbiologie , Maladies des poissons/mortalité , Edwardsiella tarda/génétique , Edwardsiella tarda/pathogénicité , Edwardsiella tarda/isolement et purification , Edwardsiella tarda/effets des médicaments et des substances chimiques , Infections à Enterobacteriaceae/microbiologie , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/mortalité , Multirésistance bactérienne aux médicaments/génétique , Antibactériens/pharmacologie , Poissons/microbiologie , Virulence/génétique , Facteurs de virulence/génétiqueRÉSUMÉ
Antimicrobial resistance is considered one of the most critical threat for both human and animal health. Recently, reports of infection or colonization by carbapenemase-producing Enterobacterales in companion animals had been described. This study report the first molecular characterization of NDM-producing Enterobacterales causing infections in companion animals from Argentina. Nineteen out of 3662 Enterobacterales isolates analyzed between October 2021 and July 2022 were resistant to carbapenemes by VITEK2C and disk diffusion method, and suspected to be carbapenemase-producers. Ten isolates were recovered from canine and nine from feline animals. Isolates were identified as K. pneumoniae (n = 9), E. coli (n = 6) and E. cloacae complex (n = 4), and all of them presented positive synergy among EDTA and carbapenems disks, mCIM/eCIM indicative of metallo-carbapenemase production and were also positive by PCR for blaNDM gene. NDM variants were determined by Sanger sequencing method. All 19 isolates were resistant to ß-lactams and aminoglycosides but remained susceptible to colistin (100%), tigecycline (95%), fosfomycin (84%), nitrofurantoin (63%), minocycline (58%), chloramphenicol (42%), doxycycline (21%), enrofloxacin (5%), ciprofloxacin (5%) and trimethoprim/sulfamethoxazole (5%). Almost all isolates (17/19) co-harbored blaCTX-M plus blaCMY, one harbored blaCTX-M alone and the remaining blaCMY. E. coli and E. cloacae complex isolates harbored blaCTX-M-1/15 or blaCTX-M-2 groups, while all K. pneumoniae harbored only blaCTX-M-1/15 genes. All E. coli and E. cloacae complex isolates harbored blaNDM-1, while in K. pneumoniae blaNDM-1 (n = 6), blaNDM-5 (n = 2), and blaNDM-1 plus blaNDM-5 (n = 1) were confirmed. MLST analysis revealed the following sequence types by species, K. pneumoniae: ST15 (n = 5), ST273 (n = 2), ST11, and ST29; E. coli: ST162 (n = 3), ST457, ST224, and ST1196; E. cloacae complex: ST171, ST286, ST544 and ST61. To the best of our knowledge, this is the first description of NDM-producing E. cloacae complex isolates recovered from cats. Even though different species and clones were observed, it is remarkable the finding of some major clones among K. pneumoniae and E. coli, as well as the circulation of NDM as the main carbapenemase. Surveillance in companion pets is needed to detect the spread of carbapenem-resistant Enterobacterales and to alert about the dissemination of these pathogens among pets and humans.
Sujet(s)
Antibactériens , Maladies des chats , Maladies des chiens , Infections à Enterobacteriaceae , bêta-Lactamases , Animaux , Chats , Chiens , Maladies des chats/microbiologie , Maladies des chats/épidémiologie , bêta-Lactamases/génétique , Argentine/épidémiologie , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/microbiologie , Infections à Enterobacteriaceae/épidémiologie , Antibactériens/pharmacologie , Maladies des chiens/microbiologie , Maladies des chiens/épidémiologie , Tests de sensibilité microbienne , Animaux de compagnie , Enterobacteriaceae/effets des médicaments et des substances chimiques , Enterobacteriaceae/isolement et purification , Enterobacteriaceae/génétique , Enterobacteriaceae/enzymologie , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/génétique , Klebsiella pneumoniae/effets des médicaments et des substances chimiques , Klebsiella pneumoniae/génétique , Klebsiella pneumoniae/isolement et purification , Klebsiella pneumoniae/enzymologieRÉSUMÉ
AIMS: To estimate the prevalence of carbapenemase-producing Enterobacterales (CPE) carriage among pets using faecal specimens submitted to veterinary diagnostic laboratories throughout the US. A secondary aim was to employ whole-genome sequencing (WGS) to characterize isolates of CPE from companion animals and compare them to publicly available CPE genomes. METHODS AND RESULTS: To estimate the prevalence of CPE in companion animals in the USA, a multicenter surveillance study including 8 different veterinary diagnostic laboratories from across the USA was conducted. Briefly, remnant faecal specimens from dogs and cats were screened using two selective agar plates (CHROMID Carba and MacConkey with 1 mg/L cefotaxime and 0.125 mg/L meropenem) and presumptive CPE isolates screened by the modified carbapenemase inactivation method for carbapenemase production. A total of 2393 specimens were screened and yielded 196 isolates for carbapenemase screening. A total of 5 isolates from 4 dogs and 1 cat at 3 different veterinary diagnostic laboratories were confirmed to produce a carbapenemase (0.21%). Whole-genome sequencing (WGS) revealed two E. coli (ST167) isolates that both produced an NDM-5 carbapenemase, two Enterobacter hormaechei (ST171) isolates that produced an NDM-5 carbapenemase and a KPC-4 carbapenemase respectively and one Klebsiella oxytoca (ST199) that produced an Oxa-48-type carbapenemase. Both E. coli isolates were found to be within at least 22 SNPs of previously characterized canine and human CPE isolates. CONCLUSIONS: This study demonstrates that the prevalence of CPE among companion animals is relatively low (0.21%) but that given the genetic relatedness of animal isolates to human isolates, additional surveillance is needed.
Sujet(s)
Protéines bactériennes , Maladies des chats , Maladies des chiens , Infections à Enterobacteriaceae , Fèces , bêta-Lactamases , Animaux , Chiens , Chats , Fèces/microbiologie , États-Unis/épidémiologie , Maladies des chiens/microbiologie , Maladies des chiens/épidémiologie , Maladies des chats/microbiologie , Maladies des chats/épidémiologie , bêta-Lactamases/génétique , bêta-Lactamases/métabolisme , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/épidémiologie , Infections à Enterobacteriaceae/microbiologie , Protéines bactériennes/génétique , Protéines bactériennes/métabolisme , Prévalence , Enterobacteriaceae/génétique , Enterobacteriaceae/isolement et purification , Enterobacteriaceae/effets des médicaments et des substances chimiques , Enterobacteriaceae/enzymologie , Épidémiologie moléculaire , Antibactériens/pharmacologie , Séquençage du génome entierRÉSUMÉ
Edwardsiella piscicida causes significant economic losses to the aquaculture industry worldwide. Phage-based biocontrol methods are experiencing a renaissance because of the spread of drug-resistant genes and bacteria resulting from the heavy use of antibiotics. Here, we showed that the novel Edwardsiella phage EPP-1 could achieve comparable efficacy to florfenicol using a zebrafish model of Edwardsiella piscicida infection and could reduce the content of the floR resistance gene in zebrafish excreta. Specifically, phage EPP-1 inhibited bacterial growth in vitro and significantly improved the zebrafish survival rate in vivo (P = 0.0035), achieving an efficacy comparable to that of florfenicol (P = 0.2304). Notably, integrating the results of 16S rRNA sequencing, metagenomic sequencing, and qPCR, although the effects of phage EPP-1 converged with those of florfenicol in terms of the community composition and potential function of the zebrafish gut microbiota, it reduced the floR gene content in zebrafish excreta and aquaculture water. Overall, our study highlights the feasibility and safety of phage therapy for edwardsiellosis control, which has profound implications for the development of antibiotic alternatives to address the antibiotic crisis.
Sujet(s)
Antibactériens , Bactériophages , Edwardsiella , Infections à Enterobacteriaceae , Thiamphénicol/analogues et dérivés , Danio zébré , Animaux , Danio zébré/microbiologie , Edwardsiella/génétique , Infections à Enterobacteriaceae/microbiologie , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/thérapie , Bactériophages/génétique , Bactériophages/physiologie , Antibactériens/pharmacologie , Résistance bactérienne aux médicaments/génétique , Microbiome gastro-intestinal , Phagothérapie/méthodes , ARN ribosomique 16S/génétique , Maladies des poissons/microbiologie , Maladies des poissons/thérapie , Maladies des poissons/prévention et contrôle , Thiamphénicol/pharmacologie , Aquaculture/méthodesRÉSUMÉ
Mastitis is the most common disease of dairy cattle and can be manifested in clinical and subclinical forms. The overuse of antimicrobials in the treatment and prevention of mastitis favours antimicrobial resistance and milk can be a potential route of dissemination. This study aimed to evaluate the biological quality of bulk tank milk (BTM) and the microbiological quality and signs of mastitis of freshly milked raw milk. In addition, to evaluate antimicrobial resistance in Enterobacteriaceae and Staphylococcus spp. isolated from freshly milked raw milk. None of the farms were within the official Brazilian biological quality limits for BTM. Freshly milked raw milk with signs of clinical (CMM), subclinical (SCMM) and no signs (MFM) of mastitis were detected in 6.67%, 27.62% and 65.71% samples, respectively. Most samples of freshly milked raw milk showed acceptable microbiological quality, when evaluating the indicators total coliforms (78.10%), Escherichia coli (88.57%) and Staphylococcus aureus (100%). Klebsiella oxytoca and S. aureus were the most prevalent microorganisms in SCMM and MFM samples. Antimicrobial resistance and multidrug resistance (MDR) were observed in 65.12% and 13.95% of Enterobacteriaceae and 84.31% and 5.88% of Staphylococcus spp., respectively, isolated from both SCMM and MFM samples. Enterobacteriaceae resistant to third-generation cephalosporin (3GCR) (6.98%) and carbapenems (CRE) (6.98%) and methicillin-resistant S. aureus (MRSA) (4.88%) were observed. Antimicrobial-resistant bacteria can spread resistance genes to previously susceptible bacteria. This is a problem that affects animal, human and environmental health and should be evaluated within the one-health concept.
Sujet(s)
Antibactériens , Résistance bactérienne aux médicaments , Enterobacteriaceae , Mammite bovine , Lait , Staphylococcus , Animaux , Bovins , Lait/microbiologie , Mammite bovine/microbiologie , Enterobacteriaceae/effets des médicaments et des substances chimiques , Enterobacteriaceae/isolement et purification , Femelle , Staphylococcus/effets des médicaments et des substances chimiques , Brésil , Antibactériens/pharmacologie , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/microbiologie , Infections à Enterobacteriaceae/traitement médicamenteux , Infections à staphylocoques/médecine vétérinaire , Infections à staphylocoques/microbiologie , Infections à staphylocoques/traitement médicamenteux , Infections asymptomatiques , Tests de sensibilité microbienne/médecine vétérinaireRÉSUMÉ
Skin mucus analysis has recently been used as a non-invasive method to evaluate for fish welfare. The present research study was conducted to examine the skin mucosal immunity and skin microbiota profiles of sturgeons infected with Citrobacter freundii. Our histology results showed that the thickness of the epidermal layer of skin remained thinner, and the number of mucous cells was significantly decreased in sturgeons after infection (p < 0.05). Total protein, alanine aminotransferase, aspartate aminotransferase, superoxide dismutase, and creatine kinase levels in the mucus showed biphasic pattern (decrease and then increase). Lactate dehydrogenase, lysozyme, and acid phosphatase activities in the mucus showed an increasing trend after infection. Furthermore, 16S rRNA sequencing also revealed that C. freundii infection also affected the diversity and community structure of the skin mucus microbiota. An increase in microbial diversity (p > 0.05) and a decrease in microbial abundance (p < 0.05) after infection were noted. The predominant bacterial phyla in the skin mucus were Proteobacteria, Fusobacteria, Bacteroidetes, Firmicutes, and Actinobacteria. Specifically, the relative abundance of Fusobacteria increased after infection. The predominant bacterial genera in the skin mucus were Cetobacterium, Pelomonas, Bradyrhizobium, Flavobacterium, and Pseudomonas. The relative abundance of Cetobacterium, Pseudomonas, and Flavobacterium increased after infection. Our current research findings will provide new insights into the theoretical basis for future research studies exploring the mechanism of sturgeon infection with C. freundii.
Sujet(s)
Citrobacter freundii , Infections à Enterobacteriaceae , Maladies des poissons , Poissons , Immunité muqueuse , Microbiote , Peau , Animaux , Citrobacter freundii/immunologie , Microbiote/immunologie , Maladies des poissons/immunologie , Maladies des poissons/microbiologie , Peau/immunologie , Peau/microbiologie , Poissons/immunologie , Infections à Enterobacteriaceae/immunologie , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/microbiologie , Mucus/immunologie , Mucus/microbiologie , ARN ribosomique 16S/génétiqueRÉSUMÉ
Japanese eel, Anguilla japonica, holds significant importance in Taiwanese aquaculture. With the intensification of eel farming, the impact of Edwardsiella tarda has become increasingly severe. Consequently, the abusive use of antibiotics has risen. Bacillus subtilis natto NTU-18, a strain of Bacillus with a high survival rate in feed processing, plays a crucial role in promoting intestinal health through competitive rejection, enhancing immune responses against bacterial pathogens, and improving intestinal health by modulating gastrointestinal microbiota to produce beneficial metabolites of mice and grass carp, Ctenopharyngodon idella. This study investigated the effects of different proportions (control, 0.25 %, 0.5 %, 1 %, and 2 %) of B. subtilis natto NTU-18 added to paste feed on the growth performance, intestinal morphology, and microbiota, expression of immune-related genes, and resistance to E. tarda in Japanese glass eel. The results indicated that the growth performance of all groups with B. subtilis natto NTU-18 added was significantly higher than that of the control group and did not impact the villi morphology. The expression of immune-related genes in the kidney, specifically HSP70 and SOD, was significantly higher from 0.5 % and above than the control; however, no significant differences were observed in CAT, POD, and HSP90. In the liver, significant differences were found in HSP70 and IgM above 0.25 % compared to the control group, with no significant differences in SOD, CAT, POD, and HSP90 among all groups. Additionally, intestinal microbiota analysis revealed that the 2 % additional group had significantly lower diversity than other groups, with Cetobacterium as the dominant species. The challenge test observed that the survival rates of the 0.5 % and 1 % groups were significantly higher. This research suggests that adding 0.5 % and 1 % of B. subtilis natto NTU-18 to the diet is beneficial for Japanese glass eel's immunity, growth performance, and disease resistance.
Sujet(s)
Anguilla , Aliment pour animaux , Bacillus subtilis , Régime alimentaire , Résistance à la maladie , Maladies des poissons , Microbiome gastro-intestinal , Intestins , Probiotiques , Animaux , Microbiome gastro-intestinal/effets des médicaments et des substances chimiques , Anguilla/immunologie , Anguilla/croissance et développement , Aliment pour animaux/analyse , Résistance à la maladie/effets des médicaments et des substances chimiques , Maladies des poissons/immunologie , Régime alimentaire/médecine vétérinaire , Probiotiques/pharmacologie , Probiotiques/administration et posologie , Intestins/immunologie , Infections à Enterobacteriaceae/immunologie , Infections à Enterobacteriaceae/médecine vétérinaire , Edwardsiella tarda/physiologie , Compléments alimentaires/analyse , Immunité innée , Répartition aléatoireRÉSUMÉ
Despite carbapenems not being used in animals, carbapenem-resistant Enterobacterales (CRE), particularly New Delhi metallo-ß-lactamase-producing CRE (NDM-CRE), are prevalent in livestock. Concurrently, the incidence of human infections caused by NDM-CRE is rising, particularly in children. Although a positive association between livestock production and human NDM-CRE infections at the national level was identified, the evidence of direct transmission of NDM originating from livestock to humans remains largely unknown. Here, we conducted a cross-sectional study in Chengdu, Sichuan Province, to examine the prevalence of NDM-CRE in chickens and pigs along the breeding-slaughtering-retail chains, in pork in cafeterias of schools, and in colonizations and infections from children's hospital and examined the correlation of NDM-CRE among animals, foods and humans. Overall, the blaNDM increases gradually along the chicken and pig breeding (4.70%/2.0%) -slaughtering (7.60%/22.40%) -retail (65.56%/34.26%) chains. The slaughterhouse has become a hotspot for cross-contamination and amplifier of blaNDM. Notably, 63.11% of pork from the school cafeteria was positive for blaNDM. The prevalence of blaNDM in intestinal and infection samples from children's hospitals was 21.68% and 19.80%, respectively. whole genome sequencing (WGS) analysis revealed the sporadic, not large-scale, clonal spread of NDM-CRE along the chicken and pig breeding-slaughtering-retail chain, with further spreading via IncX3-blaNDM plasmid within each stage of whole chains. Clonal transmission of NDM-CRE is predominant in children's hospitals. The IncX3-blaNDM plasmid was highly prevalent among animals and humans and accounted for 57.7% of Escherichia coli and 91.3% of Klebsiella pneumoniae. Attention should be directed towards the IncX3 plasmid to control the transmission of blaNDM between animals and humans.
Sujet(s)
Infections à Enterobacteriaceae , Enterobacteriaceae , Enfant , Humains , Animaux , Suidae , Enterobacteriaceae/génétique , Études transversales , Antibactériens/pharmacologie , Tests de sensibilité microbienne , Poulets , Escherichia coli/génétique , bêta-Lactamases/génétique , Infections à Enterobacteriaceae/épidémiologie , Infections à Enterobacteriaceae/médecine vétérinaire , Klebsiella pneumoniae/génétique , PlasmidesRÉSUMÉ
Janus kinases (JAKs) are important components of the JAK-STAT signaling pathway and play vital roles in innate immunity, autoimmune diseases, and inflammation. However, information about JAKs remains largely unknown in the spotted seabass, a fish species of Perciformes with great commercial value in the aquaculture industry. The aims of this study are to obtain the complete cDNA sequences of JAKs (JAK1, JAK2A, JAK2B, JAK3 and TYK2) from spotted seabass and to investigate their roles upon stimulation with lipopolysaccharides (LPS) and Edwardsiella tarda, using RT-PCR, PCR and qRT-PCR methods. All five JAK genes from the spotted seabass, each encode more than 1100 amino acids residues. JAK1 and JAK3 consist of 24 exons and 23 introns, whereas JAK2A, JAK2B and TYK2 consist of 23 exons and 22 introns. Furthermore, these five spotted seabass JAKs share high sequence identities with those of other fish species in protein domain analysis, synteny analysis, and phylogenetic analysis. Moreover, these five JAK genes were ubiquitously expressed in all tissues examined from healthy fish, and inducible expressions of JAKs were observed in the intestine, gill, head kidney, and spleen following LPS treatment or E. tarda infection. These findings indicate that all these JAK genes are involved in the antibacterial immunity of the spotted seabass and provide a basis for further understanding the mechanism of JAKs antibacterial response in the spotted sea bass.
Sujet(s)
Serran , Clonage moléculaire , Protéines de poisson , Janus kinases , Lipopolysaccharides , Phylogenèse , Animaux , Protéines de poisson/génétique , Protéines de poisson/métabolisme , Serran/génétique , Serran/immunologie , Lipopolysaccharides/immunologie , Janus kinases/métabolisme , Janus kinases/génétique , Edwardsiella tarda/physiologie , Immunité innée/génétique , Maladies des poissons/immunologie , Infections à Enterobacteriaceae/immunologie , Infections à Enterobacteriaceae/médecine vétérinaire , Séquence d'acides aminésRÉSUMÉ
NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice, lacking many components of a mature immune system, are at increased risk of disease. General understanding of potential pathogens of these mice is limited. We describe a high mortality disease outbreak caused by an opportunistic bacterial infection in NSG mice. Affected animals exhibited perianal fecal staining, dehydration, and wasting. Histopathologic lesions included a primary necrotizing enterocolitis, with inflammatory and necrotizing lesions also occurring in the liver, kidneys, heart, and brain of some mice. All affected individuals tested negative for known opportunistic pathogens of immunodeficient mice. We initially identified a member of Enterobacter cloacae complex (ECC) in association with the outbreak by traditional diagnostics. ECC was cultured from extraintestinal organs, both with and without histopathologic lesions, suggesting bacteremia. Infrared spectroscopy and MALDI-TOF mass spectrometry demonstrated that isolates from the outbreak shared molecular features and likely a common origin. We subsequently hypothesized that advanced sequencing methods would identify a single species of ECC associated with clinical disease. Using a novel targeted amplicon-based next-generation sequencing assay, we identified Enterobacter hormaechei in association with this outbreak. Knowledge of this organism as a potential opportunistic pathogen in NSG mice is critical for preclinical studies to prevent loss of animals and confounding of research.
Sujet(s)
Enterobacter , Infections à Enterobacteriaceae , Animaux , Femelle , Souris , Épidémies de maladies , Enterobacter/génétique , Enterobacter/isolement et purification , Infections à Enterobacteriaceae/médecine vétérinaire , Infections à Enterobacteriaceae/microbiologie , Séquençage nucléotidique à haut débit , Souris de lignée NODRÉSUMÉ
ß-defensin of flounder plays an important role in immunomodulation by recruiting immune cells and has a potential vaccine adjuvant effect in addition to its bactericidal activity. In this study, adjuvant effects of ß-defensin on DNA vaccine OmpC against edwardsiellosis in flounder (Paralichthys olivaceus) were investigated. The bicistronic eukaryotic expression plasmid pBudCE4.1 plasmid vector with two independent coding regions was selected to construct DNA vaccine of p-OmpC which express only the gene for the outer membrane protein of Edwardsiella tarda and the vaccine of p-OmpC-ßdefensin which express both the outer membrane protein of the bacterium and ß-defensin of flounder. In vitro and in vivo studies have shown that the constructed plasmids can be expressed in flounder embryonic cell lines and injection sites of muscles. After vaccination by intramuscular injection, both p-OmpC and p-OmpC-ßdefensin groups showed significant upregulation of immune-response. Compared to the pBbudCE4.1 and the p-OmpC vaccinated groups, the p-OmpC-ßdefensin vaccinated group showed significantly more cell aggregation at the injection site and intense immune response. The proportion of sIgM+ cells, as well as the CD4-1+ and CD4-2+ cells in both spleen and kidney was significantly higher in the p-OmpC-ßdefensin vaccinated group at peak time point than in the control groups. The relative survival rate of the p-OmpC-ßdefensin vaccine was 74.17%, which was significantly higher than that of the p-OmpC vaccinated group 48.33%. The results in this study determined that ß-defensin enhances the responses in cellular and humoral immunity and evokes a high degree of protection against E. tarda, which is a promising candidate for vaccine adjuvant.